CRISPR Therapeutics AGCRSPNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank91
3Y CAGR-0.3%
5Y CAGR+13.4%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-0.3%/yr
vs +42.8%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
-43.1pp
Decelerating
Percentile
P91
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $667.19M | +33.0% |
| 2024 | $501.57M | -15.4% |
| 2023 | $592.54M | -12.0% |
| 2022 | $673.60M | +24.8% |
| 2021 | $539.55M | +51.9% |
| 2020 | $355.15M | +46.2% |
| 2019 | $242.85M | +49.8% |
| 2018 | $162.07M | +53.4% |
| 2017 | $105.64M | +44.1% |
| 2016 | $73.29M | - |